Versions Compared

Old Version 15

changes.mady.by.user Lydia Foeken

Saved on

compared with

New Version 16

changes.mady.by.user Lydia Foeken

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

WMDA StandardTitle and link to documentExplanationStatus


Recommendation on the training of staff performing patient donor search and HLA matching activities




Suggested procedures for international unrelated search

7.01

WMDA Guidelines for subsequent donations following initial BM or PBSCs

Bone Marrow Transplantation (2011) 46: 1409-1412

This guideline is intended to outline where subsequent donations would routinely be considered appropriate (from the donor's point-of-view), as well as the frequency and timing of such donations.

Under review, see https://share.wmda.info/x/8qWbEw

for more information

3.03, 3.06, 6.06

Donor commitment and patient needs

Bone Marrow Transplantation (2004) 33: 225-230

This paper describes ethical issues related to the donation of hematopoietic stem cell products with respect to recruitment, evaluation, workup, and follow-up of unrelated donors.Current (2017)




...

WMDA StandardTitle and link to documentExplanationStatus

8.05

Recommendation for recombinant human G-CSF (G-CSF) that stem cell registries can use - the use of biosimilar G-CSF

WMDA recommendation on the use of biosimilar filgrastimsCurrent (2018)

Remunation


Labeling






Post-donation

...

WMDA StandardTitle and link to documentExplanationStatus

3.04, 3.05, 3.06, 3.09, 3.10.1, 3.11, 3.11.1, 3.13, 3.15

Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.

Bone Marrow Transplantation (2003) 31: 539-545

This is a checklist to set up an informed consent at the various stages. The paper has been replaced by the WMDA Guidance to explain the WMDA Standards. The guidance can be found at: https://share.wmda.info/x/0wB7CwOut of date


Standards, regulations  and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.

Bone Marrow Transplantation (2010), 45:819-824

WMDA has developed online documentation to explain the accreditation process, which is available at WMDA Share under the pillar: 'Ensuring Quality'Out of date

International exchange of cord blood units; the registry aspects

Bone Marrow Transplantation (2010), 45: 825-831

Replaced by chapter 6 of the WMDA handbook: a gift of lifeOut of date
8.05

Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilisation of stem cells in normal donors: position of World Marrow Donor Association.

Haematologica (2011): 96:942-943

The aim of this paper is to review the basis of regulatory approval of the biosimilar G-CSF agents, including the available safety data, with reference to the indication for mobilization of PBSC in normal donors and to make recommendations based on these.

The recommendation has been updated in 2017.

Out of date

























Page Tree
root@home
excerpttrue